Vice President Pharmacometrics
Certara
Boston, Massachusetts, United States
Mirjam N. Trame, Pharm.D., Ph.D.; VP, Certara Drug Development Solutionsm US Lead Pharmacometrics Division-II
Mirjam Trame is a pharmacometrics consultant within Certara Drug Development Solutions and the US Lead for Pharmacometrics Division-II. She provides expert support to a variety of different modalities including complex biologics, cell and gene therapy, and radiotherapeutics. Prior to joining Certara in early 2022, Mirjam worked in clinical development, clinical pharmacology, pharmacometrics and systems pharmacology in industry and academia for > 20 years with a focus on complex biologics and cell and gene therapy for > 5 years.
She received her Ph.D. in Clinical Pharmacology and Pharmacometrics from the Westfaelische-Wilhelms Universitaet in Muenster, Germany, her Pharm.D. from the University of Florida and her B.S. in Pharmaceutical Sciences from the Westfaelische-Wilhelms Universitaet in Muenster, Germany.
Disclosure(s): No financial relationships to disclose
Mind the gap – successful bridging of QSP and PMX in drug development
Monday, November 11, 2024
3:15 PM – 4:45 PM MST
Joined PMX and QSP modeling to guide step-up dosing of a bispecific antibody for prostate cancer
Monday, November 11, 2024
3:15 PM – 3:35 PM MST
Monday, November 11, 2024
4:10 PM – 4:45 PM MST
Tutorial: Using Past Models to Bridge to Open Models and Open Science using nlmixr2
Thursday, November 14, 2024
8:00 AM – 12:00 PM MST